Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of actions⃞

We have identified a series of potent cholesteryl ester transfer protein (CETP) inhibitors, one member of which, torcetrapib, is undergoing phase 3 clinical trials. In this report, we demonstrate that these inhibitors bind specifically to CETP with 1:1 stoichiometry and block both neutral lipid and...

Full description

Bibliographic Details
Main Authors: Ronald W. Clark, Roger B. Ruggeri, David Cunningham, Mark J. Bamberger
Format: Article
Language:English
Published: Elsevier 2006-03-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520336087